Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)

Clinical trial NCT05686408 · COMPLETED

Trial details

NCT number: NCT05686408
Sponsor: Tonix Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depression Depressive Disorder Depressive Symptoms Depressive Disorder, Major Depressive Episode Depression Severe

Start date: 2023-03-02
Primary completion: 2023-09-29
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.